Dysregulated Sialylation in Cancer: From Immunosuppressive Microenvironment to Siglec-Targeted Therapeutics
Abstract
Share and Cite
Zhang, Y.; Gao, Z.; Zhang, Y.; Ai, S.; Li, W.; Sun, L. Dysregulated Sialylation in Cancer: From Immunosuppressive Microenvironment to Siglec-Targeted Therapeutics. Biomolecules 2025, 15, 1375. https://doi.org/10.3390/biom15101375
Zhang Y, Gao Z, Zhang Y, Ai S, Li W, Sun L. Dysregulated Sialylation in Cancer: From Immunosuppressive Microenvironment to Siglec-Targeted Therapeutics. Biomolecules. 2025; 15(10):1375. https://doi.org/10.3390/biom15101375
Chicago/Turabian StyleZhang, Yuecheng, Zhengyao Gao, Yuhan Zhang, Siqin Ai, Wenyan Li, and Lingbo Sun. 2025. "Dysregulated Sialylation in Cancer: From Immunosuppressive Microenvironment to Siglec-Targeted Therapeutics" Biomolecules 15, no. 10: 1375. https://doi.org/10.3390/biom15101375
APA StyleZhang, Y., Gao, Z., Zhang, Y., Ai, S., Li, W., & Sun, L. (2025). Dysregulated Sialylation in Cancer: From Immunosuppressive Microenvironment to Siglec-Targeted Therapeutics. Biomolecules, 15(10), 1375. https://doi.org/10.3390/biom15101375